{"slideshow_credits": null, "snippet": "With its best-selling drugs losing patent protection, Pfizer is shedding money-making but noncore businesses to focus on pharmaceutical sciences.", "abstract": "Pfizer reports 19 percent profit decline, largely due to loss of sales of Lipitor, its best-selling drug, which lost patent protection in 2011; company reports earnings of $1.79 billion last quarter, or 24 cents a share, compared to $2.22 billion, or 28 cents a share over the same period last year.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/05/02/business/pfizer-profit-declines-19-after-loss-of-lipitor-patent.html", "lead_paragraph": "With its best-selling drugs losing patent protection, Pfizer is shedding money-making but noncore businesses to focus on pharmaceutical sciences.", "headline": {"seo": "Pfizer Profit Declines 19% After Loss of Lipitor Patent", "main": "Pfizer Races to Reinvent Itself", "print_headline": "Pfizer Profit Declines 19% On Slumping Lipitor Sales"}, "_id": "53f64f1838f0d821a37b1fbe", "word_count": "1179", "multimedia": [{"height": 75, "url": "images/2012/05/02/business/JP-PFIZER-2/JP-PFIZER-2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/05/02/business/JP-PFIZER-2/JP-PFIZER-2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-05-02T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Pfizer Inc", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Inventions and Patents", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Research", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Lipitor (Drug)", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Budgets and Budgeting", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Company Reports", "name": "subject", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}